The Acceleration Consortium (AC) at the University of Toronto and the Structural Genomics Consortium (SGC) announced today a formalized partnership to help tackle a persistent challenge in biomedicine ...
Global chipmaker giant NVIDIA kicked off JPM Week with several partnership announcements, most notably a billion dollar partnership with Indianapolis-based Eli Lilly. "Biology is on the verge of its ...
Artificial intelligence is rapidly learning to autonomously design and run biological experiments, but the systems intended to govern those capabilities are struggling to keep pace. AI company OpenAI ...
There are few things as frustrating when you’re trying to get some serious hacking done than intruders repeatedly showing up without permission. [All Parts Combined] has the solution for you, with a ...
Data silos are the enemy of efficiency, and in modern bioprocessing environments, fragmented information flows translate directly into delayed decisions, compliance risk, and lost process insight.
The BioXplorer 5000 is a lab-scale bioreactor platform available in sizes ranging from 1-5L and in high- and low-pressure variants. It can be utilized for a huge variety of applications, ranging from ...
Apple may skip the high-end M6 chips and shift premium Macs to AI-focused M7 processors, making the upgrade decision tougher for power users. If you can only read one tech story a day, this is it. We ...
Dutch block US takeover of Solvinity as against public interest The Dutch government on Tuesday blocked Kyndryl’s 100 million euro ($113 million) takeover of cloud services provider Solvinity, citing ...
Charles River beats quarterly estimates on steady demand for drug development services Contract drug developer Charles River Laboratories on Thursday beat Wall Street expectations for first-quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results